This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ESOU18
ESOU18 Bladder Cancer
Conferences
ESOU18
Prostate Cancer
Renal Cancer
Bladder Cancer
Testis & Penile Cancers
EAU 2014
Viewing 41-60 of 62 articles
EAU 2014 - State-of-the-art lecture: Diagnostic dilemmas and risks in testicular cancer - Session Highlights
EAU 2014 - State-of-the-art lecture: How to avoid cystectomy being too late in non-muscle-invasive bladder cancer - Session Highlights
EAU 2014 - State-of-the-art lecture: Personalized urinary diagnostics - Session Highlights
EAU 2014 - Adjuvant treatment of non-muscle-invasive bladder cancer: When and how? - Session Highlights
EAU 2014 - Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series - Session Highlights
EAU 2014 - The added value of intracorporeal urinary diversion after robotic radical cystectomy: A propensity matched comparative study - Session Highlights
EAU 2014 - Is estimated GFR a reliable measurement after cystectomy and ileal loop diversion? - Session Highlights
EAU 2014 - Pre-clinical and clinical translation of a tissue engineered neo−urinary conduit using adipose derived smooth muscle cells for urinary reconstruction - Session Highlights
EAU 2014 - The curative potential of lymphadenectomy after response to chemotherapy in patients with urothelial carcinoma presenting with regional or distant nodal metastases: Analysis of a series from a tertiary cancer centre - Session Highlights
EAU 2014 - Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy - Session Highlights
EAU 2014 - Debate: Surgical treatment of muscle invasive bladder cancer: Cost comparison analysis - Session Highlights
EAU 2014 - HPV prevalence in penile cancer and association with clinical outcome - Session Highlights
EAU 2014 - Has centralisation of penile cancer services in the United Kingdom improved survival? - Session Highlights
EAU 2014 - Protocol based versus non-protocol based discontinuation in the Prostate Cancer Research International: Active Surveillance (PRIAS) study - Session Highlights
EAU 2014 - Active surveillance in 853 men with low and intermediate risk prostate cancer - Session Highlights
EAU 2014 - Comparison of white-light, photodynamic diagnosis and narrow-band imaging for the detection of non-muscle invasive bladder cancer: Results from a randomized multicenter diagnostic phase-III study - Session Highlights
EAU 2014 - Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma - Session Highlights
EAU 2014 - EAU Guidelines snapshot: Testosterone supplementation and prostate cancer - Session Highlights
Real-world patient survey data shows negative impact of nocturia
GenomeDx Biosciences announces data on genomic tests for prostate and bladder cancer to be presented at EAU annual meeting
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free